Page last updated: 2024-12-08

nanaomycin e

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

nanaomycin E: epoxy deriv of nanaomycin A; see also nanaomycin A: 52934-83-5, nanaomycin B: 52934-85-7, nanaomycin C: 58286-55-8; RN in 9th CI for nanaomycin D: 60325-08-8; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID175109
MeSH IDM0080678

Synonyms (6)

Synonym
nanaomycin e
4a,10a-epoxy-1h-naphtho(2,3-c)pyran-3-acetic acid, 3,4,5,10-tetrahydro-5,10-dioxo-9-hydroxy-1-methyl-, (1s-(1-alpha,3-beta,4a-beta,10a-beta))-
4a,10a-epoxy-1h-naphtho(2,3-c)pyran-3-acetic acid, 3,4,5,10-tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-, (1s-(1alpha,3beta,4abeta,10abeta))-
72660-52-7
DTXSID50222977
SVGOJJZXRJJDLY-IUFZWFJJSA-N
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]